SalaryGuide
AboutPricingFor Employers

Marketing jobs

4 marketing jobs

Recor Medical logo
3 weeks ago

Sr. Marketing Communications Manager

Recor Medical

Palo Alto, CA (On-site)Full time$177K/yr – $195K/yr
Recor Medical logo
3 months ago

Events & Marketing Operations Manager

Recor Medical

Palo Alto, CA (On-site)Full time$157K/yr – $183K/yr
Recor Medical logo
4 months ago

Senior Manager- Direct to Patient Marketing

Recor Medical

Palo Alto, CA (Remote)Full time$183K/yr – $199K/yr
Recor Medical logo
4 months ago

Marketing Manager, Downstream Marketing

Recor Medical

Palo Alto, CA (On-site)Full time$166K/yr – $188K/yr

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Recor Medical logo

Sr. Marketing Communications Manager

Recor Medical

Palo Alto, CA (On-site)

$177K/yr - $195K/yrIn-houseFull-timeSenior level7+ years exp.
3 weeks ago
Recor Medical logo

Events & Marketing Operations Manager

Recor Medical

Palo Alto, CA (On-site)

$157K/yr - $183K/yrIn-houseFull-timeManager5+ years exp.
3 months ago
Recor Medical logo

Senior Manager- Direct to Patient Marketing

Recor Medical

Palo Alto, CA (Remote)

$183K/yr - $199K/yrIn-houseFull-timeSenior level8+ years exp.
4 months ago
Recor Medical logo

Marketing Manager, Downstream Marketing

Recor Medical

Palo Alto, CA (On-site)

$166K/yr - $188K/yrIn-houseFull-timeMid level5+ years exp.
4 months ago
Recor Medical logo
Recor Medical

Sr. Marketing Communications Manager

Palo Alto, CA (On-site)

$177K/yr – $195K/yrSenior Level7+ years expFull time

Posted 3 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the development and execution of multi-channel marcom strategies and campaigns, from concept through performance measurement, while leading content creation, creative direction, and vendor management.

  • Drive cross-channel programs from ideation to deployment
  • Leverage insights to refine audience journeys and content
  • Oversee budgets and external partners

Job Description

Responsibilities

  • Marcom Strategy and Content Development
  • Develop and execute integrated strategies across channels (e.g., Web, email, social media, print, experiential) and audiences (external and internal) to support business, brand, and marketing objectives
  • Lead the creation of compelling content as an individual contributor and with vendors to deploy across channels for target customer segments
  • Build and manage comprehensive campaigns from concepting through deployment and performance measurement
  • Champion the implementation of new tools, methods, and best practices to reach and engage audiences
  • Creative Direction (visual, verbal, and experiential)
  • As an individual contributor or with vendors, develop marketing materials from concept to production in collaboration with the Marketing team
  • Provide subject matter expertise, consulting with the Marketing team on design, brand, and copywriting
  • Select and manage relationships with vendors to deliver creative that is on strategy, on brand, on time, and on budget
  • Analysis, Insights, and Measurement

Requirements

  • 7+ years of experience working in marketing or marketing communications role in Medical Devices or similar industry
  • 5+ years of experience developing multi-channel marketing communications content, including hands-on copywriting, editing, and art/design direction
  • 5+ years of vendor selection and management experience
  • 5+ years of budget forecasting and management experience
  • Excellent attention to detail
  • Exemplary written and verbal communication skills
  • Excellent analytical and project management skills
  • Self-starter driven to execute and continually improve
  • Strong intellectual curiosity with the desire to learn best practices and improve effectiveness
  • Ability to operate in a dynamic business environment

Preferred

  • - Hands-on graphic design experience
  • - Proficiency in latest Adobe Creative Cloud programs
  • - Downstream marketing experience
  • - Knowledge and experience in the interventional cardiology field
  • - Direct-to-patient marketing communications experience
Recor Medical logo

Recor Medical

2.9 Glassdoor

Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan,

Founded in 2009
Palo Alto, California, USA
313 employees (10 in marketing)
www.recormedical.com
40% recommend to a friend
72% CEO approval

Traffic Signals

Monthly Visitors
7.7K
Traffic Source Mix
Search
28.4%
Direct
47.5%
Referral
6.6%
Social
15.9%
Paid
1.5%

Headcount Trend

Current headcount: ~313

Marketing Team

Marketing Team Size
10 (3% of company)
Median Career Experience
19 years
Median Tenure
3.3 years
Marketing Roles Posted (Last 30 Days)
1

People

HR / Recruitment

Helen N.
Helen N.
Principal Technical Recruiter
At the company for 1 year 9 months
Dominik Madre
Dominik Madre
HR Process Manager EMEA
At the company for 2 years 7 months

Marketing Leadership

Stephen Kam
Stephen Kam
Vice President Marketing and Market Access
At the company for 2 years 5 months
Zach Finley
Zach Finley
Sr. Director, Marketing & Corporate Communications
At the company for 5 years
Kyoko Koizumi
Director, Global and US Marketing
At the company for 6 years 1 month
Kristen Easterday
Kristen Easterday
Director of Marketing
At the company for 8 years 11 months

Funding

Total Funding
$25M
Last Raise
$10M
Debt Financing, 10 years ago

Funding History

  • Jun 2016
    Debt Financing • $10M
  • Apr 2015
    Series D • $15M

Recent News

CMS approves coverage for Recor Medical renal denervation study
Nov 22, 2025 • MassDevice
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 months with Recor Medical's Paradise Ultrasound Renal Denervation System
Nov 3, 2025 • PR Newswire
Recor Medical shares positive renal denervation data at TCT
Oct 30, 2025 • MassDevice
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
Oct 29, 2025 • MedTech Dive
CMS finalizes renal denervation coverage that benefits Medtronic, Recor
Oct 28, 2025 • MassDevice
CMS Issues National Coverage Determination for Recor
Oct 28, 2025 • GlobeNewswire
Recor Medical gains historic approval for its ultrasound RDN system
Aug 29, 2025 • Cardiovascular Business
Otsuka Medical Devices Receives Manufacturing and Marketi...
Aug 25, 2025 • PharmiWeb
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
Aug 25, 2025 • Recor Medical
Otsuka Medical Devices Receives Manufacturing and Marketing Approval for Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension First in Japan
Aug 25, 2025 • BioSpace
New blood pressure treatment guidelines add recommendations for renal denervation
Aug 18, 2025 • FierceBiotech
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
Aug 15, 2025 • Recor Medical
Renal Denervation Device Market Expected to Hit 1.5 Billion USD by 2032 with Strong 40.90% CAGR
Aug 6, 2025 • EIN Presswire
Medtronic, Recor praise new CMS coverage for renal denervation
Jul 11, 2025 • MassDevice
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
Jul 10, 2025 • Yahoo Finance
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
Jul 10, 2025 • Morningstar.com
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
Jul 10, 2025 • GlobeNewswire News Room
A New Option for Treating High Blood Pressure is Available to United States Veterans
May 16, 2025 • The Malaysian Reserve
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
May 16, 2025 • Morningstar.com
Innovations in High Blood Pressure Intervention Benefit Patients with Resistant Hypertension
May 16, 2025 • Recor Medical
A New Option for Treating High Blood Pressure is Available to United States Veterans
May 16, 2025 • PR Newswire
Court revives renal denervation patent battle between ReCor, Medtronic
Apr 3, 2025 • MassDevice
Medtronic, Recor commence hostilities over RDN patents
Apr 2, 2025 • BioWorld MedTech
Use of the Paradise™ Ultrasound Renal Denervation (uRDN) System for Treatment of Uncontrolled Hypertension
Mar 5, 2025 • HMP Global Learning Network
Recor Medical Statement on CMS National Coverage Analysis of Renal Denervation for the Treatment of Hypertension
Jan 14, 2025 • The Manila Times
Recor Medical Statement on CMS National Coverage Analysis of Renal Denervation for the Treatment of Hypertension
Jan 13, 2025 • Morningstar, Inc.
CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation
Nov 8, 2024 • Diagnostic and Interventional Cardiology
Medtronic & Recor’s Renal Denervation Solutions Secure Reimbursement
Nov 7, 2024 • Medical Device and Diagnostic industry
CMS hands Medicare payment to renal denervation systems from Medtronic, Recor Medical
Nov 6, 2024 • Fierce Biotech
Medtronic, Recor Medical score renal denervation reimbursement wins
Nov 5, 2024 • MassDevice
Medtronic, Recor win CMS transitional payment coverage for renal denervation devices
Nov 5, 2024 • MedTech Dive
Recor Medical announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
Nov 1, 2024 • Yahoo Finance
Ultrasound-based neuromodulation system
Aug 28, 2024 • Google Patent
First Patients Treated in Recor Medical’s Global Paradise
Jul 25, 2024 • GlobeNewswire
Recor Medical Announces First Cases of Paradise Ultrasound Renal Denervation Therapy in the United Arab Emirates
Apr 19, 2024 • Yahoo Finance
Dr. med. Nikolaos Dagkonakis on LinkedIn: #cardiospot #freiburg #astrazeneca
Apr 17, 2024 • LinkedIn
Recor Medical on LinkedIn: #sir2024 #paradiseurdn #hypertension #renaldenervation
Apr 17, 2024 • LinkedIn
Recor Medical CEO Lara Barghout on leadership lessons and what she looks for when hiring
Dec 21, 2023 • Medical Design & Outsourcing
Paradise Ultrasound Renal Denervation Lands Breakthrough ...
Dec 17, 2023 • The Healthcare Technology Report.
Fast Five: Recor Medical wins first FDA nod for renal ...
Nov 24, 2023 • MassDevice
Recor Medical launches renal denervation system, announces first commercial cases
Nov 13, 2023 • MassDevice
ReCor Medical’s ultrasound renal denervation system launches in Europe
Jan 1, 1970 • Mass Device
ACC 2019 Roundup – ReCor touts six-month Paradise renal denervation study results
Jan 1, 1970 • Mass Device
Otsuka Medical Devices and Recor Medical Announce Positiv...
Jan 1, 1970 • PharmiWeb.com
ReCor Medical completes enrollment in renal denervation trial for treating hypertension
Jan 1, 1970 • Mass Device
ReCor Medical, Otsuka say renal denervation system met primary endpoint in U.S. study
Jan 1, 1970 • Mass Device
Sofinnova Partners sells ReCor Medial
Jan 1, 1970 • PE HUB
ReCor Medical taps Siemens alum as CEO amid FDA review of renal denervation system
Jan 1, 1970 • FierceBiotech
ReCor Medical Names Lara Barghout President and Chief Executive Officer
Jan 1, 1970 • BioSpace
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
Jan 1, 1970 • PRNewswire